Ipamorelin
The first selective growth hormone secretagogue with no cortisol stimulation—a critical safety advantage over other GHRPs.
Also known as: GHRP-1 Derivative, Selective GHS
Available on Forge Amino
Ipamorelin 10MG — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Pentapeptide that selectively binds ghrelin receptor (GHSR-1a) on somatotroph cells, triggering GH pulse amplitude without off-target ACTH or cortisol release.
Key Benefits
- ✓Pulsatile GH release (physiologic pattern)
- ✓No cortisol or prolactin elevation
- ✓Enhanced muscle protein synthesis
- ✓Improved bone density
- ✓Enhanced GH secretion when stacked with CJC
Dosing Protocols
Beginner / Intermediate
Dose
100-200 mcg
Frequency
Before bed subcutaneous
Cycle Length
8-12 weeks
Notes
Inject on empty stomach; 2-3 injections daily optimal
Advanced
Dose
200-300 mcg
Frequency
2-3 times daily subcutaneous
Cycle Length
12-16 weeks
Notes
Bedtime injection most important; peak 40 min post-injection
Side Effects & Safety
Common Side Effects
- Appetite stimulation
- Mild nausea or dizziness
- Injection site reactions (minimal)
- Very safe; no serious AEs in trials
Contraindications
- Pregnancy and breastfeeding
- Active cancer or cancer history
- Acute critical illness
- Growth hormone-secreting tumors
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Selective GH amplification: Ipamorelin triggers GH pulses without cortisol—the safest GHRP available.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.